Ajaypal Singh to Drug Labeling
This is a "connection" page, showing publications Ajaypal Singh has written about Drug Labeling.
Connection Strength
0.087
-
The FDA's perspective on the risk for rapid rise in hemoglobin in treating CKD anemia: Quo Vadis. Clin J Am Soc Nephrol. 2010 Apr; 5(4):553-6.
Score: 0.087
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.